Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation

Aberrant activation of the transcription factor NF-κB, as well as uncontrolled inflammation, has been linked to autoimmune diseases, development and progression of cancer, and neurological disorders like Alzheimer’s disease. Reporter cell lines are a valuable state-of-the art tool for comparative an...

Full description

Saved in:
Bibliographic Details
Main Authors: Marie-Theres Zeuner, Thomas Vallance, Sakthivel Vaiyapuri, Graeme S. Cottrell, Darius Widera
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/6209865
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556643227795456
author Marie-Theres Zeuner
Thomas Vallance
Sakthivel Vaiyapuri
Graeme S. Cottrell
Darius Widera
author_facet Marie-Theres Zeuner
Thomas Vallance
Sakthivel Vaiyapuri
Graeme S. Cottrell
Darius Widera
author_sort Marie-Theres Zeuner
collection DOAJ
description Aberrant activation of the transcription factor NF-κB, as well as uncontrolled inflammation, has been linked to autoimmune diseases, development and progression of cancer, and neurological disorders like Alzheimer’s disease. Reporter cell lines are a valuable state-of-the art tool for comparative analysis of in vitro drug screening. However, a reporter cell line for the investigation of NF-κB-driven neuroinflammation has not been available. Thus, we developed a stable neural NF-κB-reporter cell line to assess the potency of proinflammatory molecules and peptides, as well as anti-inflammatory pharmaceuticals. We used lentivirus to transduce the glioma cell line U251-MG with a tandem NF-κB reporter construct containing GFP and firefly luciferase allowing an assessment of NF-κB activity via fluorescence microscopy, flow cytometry, and luminometry. We observed a robust activation of NF-κB after exposure of the reporter cell line to tumour necrosis factor alpha (TNFα) and amyloid-β peptide [1-42] as well as to LPS derived from Salmonella minnesota and Escherichia coli. Finally, we demonstrate that the U251-NF-κB-GFP-Luc reporter cells can be used for assessing the anti-inflammatory potential of pharmaceutical compounds using Bay11-7082 and IMD0354. In summary, our newly generated cell line is a robust and cost-efficient tool to study pro- and anti-inflammatory potential of drugs and biologics in neural cells.
format Article
id doaj-art-e3928681c3fc4edb92c6d30641aab78a
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-e3928681c3fc4edb92c6d30641aab78a2025-02-03T05:44:55ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/62098656209865Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of NeuroinflammationMarie-Theres Zeuner0Thomas Vallance1Sakthivel Vaiyapuri2Graeme S. Cottrell3Darius Widera4Stem Cell Biology and Regenerative Medicine, School of Pharmacy, University of Reading, Reading RG6 6AP, UKStem Cell Biology and Regenerative Medicine, School of Pharmacy, University of Reading, Reading RG6 6AP, UKSchool of Pharmacy, University of Reading, Reading RG6 6AP, UKCellular and Molecular Neuroscience, School of Pharmacy, University of Reading, Reading RG6 6AP, UKStem Cell Biology and Regenerative Medicine, School of Pharmacy, University of Reading, Reading RG6 6AP, UKAberrant activation of the transcription factor NF-κB, as well as uncontrolled inflammation, has been linked to autoimmune diseases, development and progression of cancer, and neurological disorders like Alzheimer’s disease. Reporter cell lines are a valuable state-of-the art tool for comparative analysis of in vitro drug screening. However, a reporter cell line for the investigation of NF-κB-driven neuroinflammation has not been available. Thus, we developed a stable neural NF-κB-reporter cell line to assess the potency of proinflammatory molecules and peptides, as well as anti-inflammatory pharmaceuticals. We used lentivirus to transduce the glioma cell line U251-MG with a tandem NF-κB reporter construct containing GFP and firefly luciferase allowing an assessment of NF-κB activity via fluorescence microscopy, flow cytometry, and luminometry. We observed a robust activation of NF-κB after exposure of the reporter cell line to tumour necrosis factor alpha (TNFα) and amyloid-β peptide [1-42] as well as to LPS derived from Salmonella minnesota and Escherichia coli. Finally, we demonstrate that the U251-NF-κB-GFP-Luc reporter cells can be used for assessing the anti-inflammatory potential of pharmaceutical compounds using Bay11-7082 and IMD0354. In summary, our newly generated cell line is a robust and cost-efficient tool to study pro- and anti-inflammatory potential of drugs and biologics in neural cells.http://dx.doi.org/10.1155/2017/6209865
spellingShingle Marie-Theres Zeuner
Thomas Vallance
Sakthivel Vaiyapuri
Graeme S. Cottrell
Darius Widera
Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
Mediators of Inflammation
title Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
title_full Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
title_fullStr Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
title_full_unstemmed Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
title_short Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
title_sort development and characterisation of a novel nf κb reporter cell line for investigation of neuroinflammation
url http://dx.doi.org/10.1155/2017/6209865
work_keys_str_mv AT mariethereszeuner developmentandcharacterisationofanovelnfkbreportercelllineforinvestigationofneuroinflammation
AT thomasvallance developmentandcharacterisationofanovelnfkbreportercelllineforinvestigationofneuroinflammation
AT sakthivelvaiyapuri developmentandcharacterisationofanovelnfkbreportercelllineforinvestigationofneuroinflammation
AT graemescottrell developmentandcharacterisationofanovelnfkbreportercelllineforinvestigationofneuroinflammation
AT dariuswidera developmentandcharacterisationofanovelnfkbreportercelllineforinvestigationofneuroinflammation